Skip to content

Evaluation of CT CAD software for the diagnosis of pneumonia: a retrospective, multi-center trial

Evaluation of CT CAD software for the diagnosis of pneumonia: a retrospective, multi-center trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042821
Enrollment
Unknown
Registered
2021-01-29
Start date
2020-04-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia / Novel Coronavirus Pneumonia (COVID-19)

Interventions

CAD&#32
for&#32
the&#32
diagnosis&#32
of&#32
pneumonia

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 96 Years

Inclusion criteria

Inclusion criteria: Subjects who can join this study must meet all of the following conditions: 1) Picture data with clear lung CT image effect; 2) The lung CT plain scan image quality is qualified (no breathing and motion artifacts); 3) Lung CT contains reconstruction sequence of lung window thickness <= 2 mm; 4) Those with clear clinical diagnosis results.

Exclusion criteria

Exclusion criteria: Subjects should not participate in the trial in any of the following situations: 1) There is a history of lung surgery or chest trauma such as traumatic pneumothorax and liquid pneumothorax, lung contusion, lung laceration, etc.; 2) During the diagnosis and treatment period, patients with mild new coronavirus infection with no pneumonia imaging features on lung CT; 3) The image data has been adopted by the software product training data set; 4) The CT images of the lungs do not meet the imaging diagnostic requirements of the test product, such as non-pulmonary scans, incomplete lung scans, discontinuous sequence images, discontinuous physical spatial positions of the images, etc.; 5) Repeated entry; 6) Other researchers consider it not suitable for participating in clinical trials.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactHaibo Xu

Tencent HealthCare (Shenzhen) Co., Ltd.

xuhaibo1120@hotmail.com+86 13545009416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026